Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones

What Was Tested

This randomized controlled trial paper looks at Cholecystokinin (CCK) in the context of gallbladder and gallstones.

Who Took Part

According to the abstract, 15 patients were involved.

The age groups tagged for this paper are adults, middle-aged adults and older adults, both men and women.

A double-blind study was performed on 15 patients, 7 randomised to UDCA and 8 to placebo, treated for 4 weeks before cholecystectomy.

How the Study Was Run

The researchers set it up as a randomized, double-blind and placebo-controlled study.

The patients were allocated by chance, so the Cholecystokinin (CCK) group and the comparison group should start out alike.

Blinding on both sides kept the patients and researchers unaware of who received Cholecystokinin (CCK).

Some patients received a placebo instead of Cholecystokinin (CCK), giving a reference point.

A time span of 4 weeks appears in the methods.

Muscle contraction induced by cholecystokinin (CCK)-8, acetylcholine (ACh) and potassium chloride (KCl) was determined in enzymatically isolated GB muscle cells, and cholesterol levels were determined in plasma membranes.

H(2)O(2), lipid peroxidation, platelet-activating factor (PAF)-like lipids, prostaglandin E(2) (PGE(2)) and catalase activity were determined as biochemical markers of oxidative stress and inflammation in muscle cells.

What Was Measured

Topics PubMed links to this paper include Acetylcholine, Cell Membrane, Cells, Cultured, Cholecystitis, Acute, Cholecystokinin, Cholesterol and Gallstones.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Cholecystokinin (CCK) in 15 patients in people with gallbladder and gallstones over 4 weeks.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The abstract goes on to report its results in about 3 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2007 (Gut), a journal based in England.

More context: the Cholecystokinin (CCK) compound page, Gallbladder and gallstones research.